Tag: Secukinumab
Bio-Rad extends range of anti-idiotypic antibodies for bioanalysis & drug monitoring
Highly selective recombinant monoclonal antibodies targeting Brentuximab Vedotin, Secukinumab, and their biosimilars
Novartis launches biologic treatment option for psoriasis
Scapho® (secukinumab) has been approved by the Drug Controller General of India (DCGI) for the treatment...